Metallus MTUS Balance Sheet Review Q4 2025 EPS Misses Estimates Aptevo APVO Sector Impact Aptevo Therapeutics posts 999 EPS surprise far narrower loss than expected BXP Inc BXP far outpaces fourth quarter 2025 EPS estimates registers small year over year revenue gain as shares tick higher Eupraxia Pharmaceuticals EPRX Q1 2026 Miss What Went Wrong Michael Saylor Tokenization Will Create a Free Market for Yield Challenging Traditional Banking Caris Life Sciences CAI Climbs 15 as Shares Test Resistance at 1674 Stock Split Strategies Evaluating LongTerm Opportunities After Market Pullbacks Walmart Inc WMT Attracts Analyst Attention Amid Evolving Retail Landscape Best HighYield Savings Rates Today Up to 410 APY Available as Fed Holds Rates Steady in 2026 Soybean Futures Under Pressure Amid Harvest Progress and Demand Uncertainty Jim Cramer Highlights VF Corps Turnaround Efforts Amid Apparel Sector Challenges Bank of Scotland Unveils LimitedEdition 20 Note Featuring Scott McTominays Iconic Goal OpenAIs ChatGPT Now Links to Financial AccountsPrivacy Experts Caution Users BiomX Inc PHGE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline ALTO Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher Amid Operational Improvements GRAL Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Udemy Inc UDMY Q1 2026 Earnings A Sharp EPS Miss Raises Questions on Profitability Biogen Q1 2026 Earnings EPS Surges Past Estimates Stock Rises MRCY Q1 2026 Earnings Massive EPS Surprise of 284 Drives Stock Higher SoundThinking SSTI Edges Higher Amid Consolidation Testing Key Resistance Zone Miluna Acquisition Corp MMTX Holds Steady at 1007 as SPAC Trading Remains Directionless Altisource Portfolio Solutions Warrants ASPSZ Slide 533 as Support at 019 Holds RF Acquisition Corp III RFAM Holds Steady at 986 as SPAC Trading Remains RangeBound IT Tech Packaging ITP Slips Further as Stock Navigates Narrow Range Near Support Levels Bill Gates Discusses Trump Meeting Musks DOGE in WSJ Interview Ahead of Memoir SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Dolby Laboratories DLB Advances 336 Testing Resistance as Bullish Momentum Builds